Effects of diet and exercise on obesity-related vascular dysfunction in children

Kam S Woo1, Ping Chook, Chung W Yu

  • 1Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong. kamsangwoo@cuhk.edu.hk

Circulation
|April 7, 2004
PubMed

Insights

Childhood obesity causes arterial dysfunction. Diet and exercise interventions can reverse this vascular dysfunction, with combined diet and exercise showing the best results for children’s vascular health.

Area of Science:

  • Pediatric cardiology
  • Vascular biology
  • Preventive medicine

Background:

  • Childhood obesity is a growing epidemic.
  • Obesity in children is linked to early arterial dysfunction and thickening.
  • These vascular changes are precursors to atherosclerosis.

Purpose of the Study:

  • To assess if lifestyle interventions can reverse obesity-related arterial dysfunction and carotid intima-media thickening in children.
  • To compare the effectiveness of diet alone versus diet plus exercise.

Main Methods:

  • 82 overweight children (9-12 years) were randomized to diet only or diet plus supervised exercise for 6 weeks, followed by 1 year.
  • Primary outcomes measured were brachial artery endothelial function and carotid intima-media thickness via ultrasound.
  • Secondary outcomes included waist-hip ratio, cholesterol, and body fat content.

Main Results:

  • Both interventions improved endothelial function, reduced waist-hip ratio, and lowered cholesterol at 6 weeks.
  • Diet plus exercise yielded greater endothelial function improvement than diet alone.
  • At 1 year, sustained improvements in vascular health and body composition were observed in children who continued exercise.

Conclusions:

  • Obesity-related vascular dysfunction in children is reversible with lifestyle changes.
  • Combined diet and exercise interventions are particularly effective.
  • Sustained adherence to diet and exercise leads to long-term vascular health benefits in children.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28